INDA vs XBI

iShares MSCI India ETF vs SPDR S&P Biotech ETF

Quick take
  • • XBI has the lower expense ratio at 0.35% vs 0.61% for INDA.
  • • XBI pays a higher dividend yield (0.35%).

Side-by-side metrics

MetricINDAXBI
Expense ratio
Annual fee. Lower is better.
0.61%0.35%
Dividend yield
Trailing 12-month yield.
0.00%0.35%
AUM
Assets under management — bigger funds are typically more liquid.
$5.84B$10.92B
YTD return
-4.88%28.80%
1-year return
——
3-year return
Annualized.
——
5-year return
Annualized.
——
10-year return
Annualized.
——
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.611.01
P/E ratio
23.08—
Last price
$51.52$156.41
Inception
——
Issuer
iSharesState Street

INDA top holdings

Top holdings · INDA
HDFCBANK.NSHDFC Bank Ltd6.28%
ICICIBANK.NSICICI Bank Ltd5.91%
RELIANCE.NSReliance Industries Ltd5.32%
BHARTIARTL.NSBharti Airtel Ltd4.40%
INFY.NSInfosys Ltd2.86%
AXISBANK.BOAxis Bank Ltd2.24%
LT.NSLarsen & Toubro Ltd2.07%
KOTAKBANK.NSKotak Mahindra Bank Ltd2.00%
M&M.NSMahindra & Mahindra Ltd1.96%
Sector breakdown · INDA
Real Estate1.4%
Consumer Cyclical12.2%
Basic Materials8.0%
Consumer Defensive5.0%
Technology8.7%
Communication Services5.5%
Financial Services29.6%
Utilities4.2%
Industrials9.9%
Energy8.0%
Healthcare7.6%

XBI top holdings

Top holdings · XBI
MRNAModerna Inc2.37%
NTRANatera Inc1.82%
HALOHalozyme Therapeutics Inc1.77%
TWSTTwist Bioscience Corp1.77%
BIIBBiogen Inc1.75%
AMGNAmgen Inc1.73%
EXELExelixis Inc1.73%
UTHRUnited Therapeutics Corp1.72%
ABBVAbbVie Inc1.71%
GILDGilead Sciences Inc1.70%
Sector breakdown · XBI
Financial Services0.6%
Healthcare99.3%

About INDA

INDA (iShares MSCI India ETF) is Indian large- and mid-cap equities. Managed by iShares, the fund carries $5.8B in assets under management, an expense ratio of 0.61%. Its largest holding is HDFC Bank Ltd (HDFCBANK.NS), which represents 6.3% of the portfolio. Real Estate is the fund's largest sector exposure at 1.4%.

About XBI

XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.